This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Aceragen Gestion
Gestion contrôle des critères 3/4
Aceragen's CEO is John Taylor, appointed in Sep 2022, he has a tenure of less than a year. His total yearly compensation is $444.06K , comprised of 17.5% salary and 82.5% bonuses, including company stock and options. He directly owns 17.45% of the company’s shares, worth $558.40K. The average tenure of the management team and the board of directors is 4.1 years and 4.3 years respectively.
Informations clés
John Taylor
Directeur général
US$444.1k
Rémunération totale
| Pourcentage du salaire du PDG | 17.5% |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | 17.5% |
| Durée moyenne d'occupation des postes de direction | 4.1yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 4.3yrs |
Mises à jour récentes de la gestion
Recent updates
Idera Pharmaceuticals completes acquisition of Aceragen
Sep 28We're Keeping An Eye On Idera Pharmaceuticals' (NASDAQ:IDRA) Cash Burn Rate
Aug 24
We Think Idera Pharmaceuticals (NASDAQ:IDRA) Needs To Drive Business Growth Carefully
May 11Is Idera Pharmaceuticals (NASDAQ:IDRA) In A Good Position To Deliver On Growth Plans?
Mar 07When Will Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Become Profitable?
Jan 31Idera outlines capital requirement to move tilsotolimod toward commercialization in advanced melanoma
Jan 13Could The Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Ownership Structure Tell Us Something Useful?
Dec 27Don't Ignore The Fact That This Insider Just Sold Some Shares In Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)
Dec 27Idera Pharmaceuticals receives $5M in additional proceeds from private placement
Dec 15We're Keeping An Eye On Idera Pharmaceuticals' (NASDAQ:IDRA) Cash Burn Rate
Nov 25Idera Pharma names new operations chief
Nov 17Idera Pharmaceuticals EPS misses by $0.37
Oct 29Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -US$41m |
| Dec 31 2022 | US$444k | US$78k | -US$23m |
Rémunération vs marché: John's total compensation ($USD444.06K) is below average for companies of similar size in the US market ($USD760.57K).
Rémunération et revenus: Insufficient data to compare John's compensation with company performance.
PDG
John Taylor (52 yo)
less than a year
Titularisation
US$444,062
Compensation
Mr. John C. Taylor serves as President, Chief Executive Officer and Director since September 28, 2022 at Aceragen, Inc. He was Chief Executive Officer of Spyryx Biosciences, Inc since December 2013 and ser...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | less than a year | US$444.06k | 17.45% $ 558.4k | |
| Associate Director of Human Resources | no data | pas de données | pas de données | |
| Director of Human Resources | no data | pas de données | pas de données | |
| Senior Vice President of Technical Operations | no data | pas de données | pas de données | |
| Global Head of Quality | no data | pas de données | pas de données | |
| Medical Director & Global Clinical Lead for Oncology | no data | pas de données | pas de données | |
| Advisor | 4.1yrs | US$993.93k | pas de données | |
| Adviser | no data | US$986.13k | pas de données |
4.1yrs
Durée moyenne de l'emploi
62yo
Âge moyen
Gestion expérimentée: ACGN's management team is considered experienced (4.1 years average tenure).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | less than a year | US$444.06k | 17.45% $ 558.4k | |
| Independent Director | 4.3yrs | US$89.43k | 0.26% $ 8.4k | |
| Chair of the Board of Directors | 8.7yrs | US$1.43m | 0.10% $ 3.2k | |
| Independent Director | less than a year | US$11.88k | pas de données | |
| Independent Director | 7.6yrs | US$66.24k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$60.12k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Member of Scientific Advisor Board | no data | pas de données | 14.31% $ 458.0k |
4.3yrs
Durée moyenne de l'emploi
63.5yo
Âge moyen
Conseil d'administration expérimenté: ACGN's board of directors are considered experienced (4.3 years average tenure).